Search clinical trials for: somavaratan

Total 8 results

Versartis Inc.
Premier Research Group plc

Terminated

Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in Adult Growth Hormone Deficiency (AGHD)

Adult Growth Hormone Deficiency (AGHD)
Versartis Inc.

Terminated

A Long-Term Safety Study of Somavaratan in Japanese Children With Growth Hormone Deficiency

Growth Hormone Deficiency

United States
Versartis Inc.

Terminated

Versartis Long-Term Safety Study of Somavaratan (VISTA)

Pediatric Growth Hormone Deficiency
Versartis Inc.
Premier Research Group plc

Completed

Versartis International Trial in Adults With Long-Acting Growth Hormone (VITAL)

Adult Growth Hormone Deficiency

United States, Australia, Germany, United Kingdom
BioWest Therapeutics Inc

Completed

Safety and Efficacy of MBI 226 2.5% and 5.0% Topical Acne Solutions in the Treatment of Acne

Acne Vulgaris | Acne | Propionibacterium Acnes
Versartis Inc.

Terminated

Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (Somavaratan, VRS-317)

Growth Disorders | Pediatric Growth Hormone Deficiency

Japan
Versartis Inc.

Completed

Long-Acting Growth Hormone in Children Compared to Daily rhGH (VELOCITY)

Growth Disorders
Ajou University School of Medicine
HK inno.N Corporation

Completed

The Effects of Anesthetic Techniques and Palonosetron Administration on the Incidence of PONV

Anesthesia | PONV | Palonosetron

Korea, Republic of

3

Subscribe